Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient.
- 2018-03
- Journal de Mycologie Médicale 28(1)
- I. Kara
- F. Yıldırım
- Ö. Özgen
- S. Ergani̇ş
- M. Aydoğdu
- M. Dizbay
- G. Gürsel
- A. Kalkancı
- PubMed: 29132794
- DOI: 10.1016/j.mycmed.2017.09.003
Study Design
- Type
- Case Report
- Sample size
- n = 2
- Population
- Critically ill patients in an intensive care unit
- Methods
- Case Series
Abstract
Saccharomyces cerevisiae is a common colonizer of the human gastrointestinal system as a benign organism. Enteral supplementation of this yeast as a probiotic product is effective in the treatment of antibiotic associated diarrhae. In rare occasions it can cause invasive infections. We present two fungemia cases in an intensive care unit following probiotic treatment containing S. boulardii. We are warning the safety of probiotic treatment in critically ill patients.
Keywords: Fungemia; Intensive care unit; Probiotic; Saccharomyces cerevisiae (boulardii).